← FDA DRUG APPROVALS

FDA ANDA · ANDA206805

CLOBETASOL PROPIONATE

Sponsor: INGENUS PHARMS LLC

APPLICATION
ANDA206805
TYPE
ANDA
ORIGINAL APPROVAL
2017-07-31
LATEST ACTION
2019-09-06
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, FOAM
MARKETING STATUS
Discontinued

Products

CLOBETASOL PROPIONATEDiscontinued
CLOBETASOL PROPIONATE 0.05% · AEROSOL, FOAM · TOPICAL

Approval history

2019-09-06Labeling · Supplement 1 · standardAP
2017-07-31UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →